Your session is about to expire
What is Prandin
Approved as Treatment by the FDA
Repaglinide, otherwise called Prandin, is approved by the FDA for 4 uses which include Diet and Type 2 Diabetes Mellitus .Effectiveness
When to interrupt dosage
The quantity of Prandin is contingent upon the diagnosed state, including Diet, Physical Activity and Type 2 Diabetes. The dosage likewise fluctuates per the mode of delivery (e.g. Tablet or Tablet - Oral) laid out in the table below.Warnings
There are 20 known major drug interactions with Prandin.Prandin Novel Uses: Which Conditions Have a Clinical Trial Featuring Prandin?
196 active studies are presently being conducted to determine the effectiveness of Prandin in Diet, Physical Activity and the management of Type 2 Diabetes.Prandin Reviews: What are patients saying about Prandin?
Patient Q&A Section about prandin
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What are the side effects of Prandin?
"Side effects from taking Benicar may include: low blood sugar, nausea, diarrhea, headache, back pain, joint pain, or cold symptoms such as a stuffy nose, sneezing, and sore throat."
What class of drugs is Prandin?
"PRANDIN is an oral diabetes medication that helps control blood sugar levels. It belongs to a class of drugs called glinides."
Is Prandin the same as metformin?
"Glucophage is the primary medication used to regulate blood sugar and lower the mortality risk associated with diabetes. A small number of people may experience digestive issues as a side effect of the medication. Prandin is a medication that rapidly lowers blood sugar, and is most effective around mealtimes."
What is Prandin used for?
"It is used in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This medication works by stimulating the body to produce more insulin."